JPS6155906B2 - - Google Patents

Info

Publication number
JPS6155906B2
JPS6155906B2 JP58051781A JP5178183A JPS6155906B2 JP S6155906 B2 JPS6155906 B2 JP S6155906B2 JP 58051781 A JP58051781 A JP 58051781A JP 5178183 A JP5178183 A JP 5178183A JP S6155906 B2 JPS6155906 B2 JP S6155906B2
Authority
JP
Japan
Prior art keywords
group
carbon atoms
formula
compound
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP58051781A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58177971A (ja
Inventor
Rarusu Eriiku Aauitsutsuson Fuoruke
Aauitsudo Emiiru Kaaruson Peru
Arufu Hatsukuseru Uri
Sutefuan Mikaeru Iyotsuto Yoon
Marugareeta Yohanson Anetsute
Renaato Rindoberui Peru
Rarusu Gunnaa Niruson Yoon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of JPS58177971A publication Critical patent/JPS58177971A/ja
Publication of JPS6155906B2 publication Critical patent/JPS6155906B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
JP58051781A 1982-03-30 1983-03-29 置換フエニルアザシクロアルカン化合物およびド−パミンレセプタ−作働剤 Granted JPS58177971A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8202023A SE446335B (sv) 1982-03-30 1982-03-30 Ren enantiomer av en metasubstituerad 3-fenyl-1-propylpiperidin
SE8202023-1 1982-03-30

Publications (2)

Publication Number Publication Date
JPS58177971A JPS58177971A (ja) 1983-10-18
JPS6155906B2 true JPS6155906B2 (en16) 1986-11-29

Family

ID=20346417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58051781A Granted JPS58177971A (ja) 1982-03-30 1983-03-29 置換フエニルアザシクロアルカン化合物およびド−パミンレセプタ−作働剤

Country Status (17)

Country Link
EP (1) EP0097628B1 (en16)
JP (1) JPS58177971A (en16)
AT (1) ATE56705T1 (en16)
AU (1) AU564287B2 (en16)
CA (1) CA1202307A (en16)
DD (1) DD209621A5 (en16)
DE (1) DE3381885D1 (en16)
DK (1) DK162214C (en16)
ES (3) ES521080A0 (en16)
FI (1) FI81088C (en16)
GB (1) GB2117771B (en16)
GR (1) GR79244B (en16)
HU (1) HU191290B (en16)
IE (1) IE55261B1 (en16)
NO (1) NO164024C (en16)
PT (1) PT76481B (en16)
SE (1) SE446335B (en16)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8305362D0 (sv) * 1983-09-30 1983-09-30 Astra Laekemedel Ab Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds
SE9904724D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
JP2011057619A (ja) * 2009-09-10 2011-03-24 Tokai Univ 光学活性アミン化合物の製造方法、並びに、ジアステレオマー塩及びその製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU542153B2 (en) * 1979-12-05 1985-02-07 Per Arvid Emil Carlsson New phenyl-azacycloalkanes

Also Published As

Publication number Publication date
IE55261B1 (en) 1990-07-18
FI831068L (fi) 1983-10-01
AU564287B2 (en) 1987-08-06
AU1284583A (en) 1983-10-06
ATE56705T1 (de) 1990-10-15
FI81088B (fi) 1990-05-31
EP0097628A2 (en) 1984-01-04
FI831068A0 (fi) 1983-03-29
DK162214B (da) 1991-09-30
PT76481A (en) 1983-04-01
HU191290B (en) 1987-02-27
SE446335B (sv) 1986-09-01
GR79244B (en16) 1984-10-22
ES8601889A1 (es) 1985-11-16
PT76481B (en) 1986-02-27
ES8405372A1 (es) 1984-06-01
NO831040L (no) 1983-10-03
GB2117771A (en) 1983-10-19
DK143483D0 (da) 1983-03-29
NO164024B (no) 1990-05-14
CA1202307A (en) 1986-03-25
EP0097628B1 (en) 1990-09-19
ES539031A0 (es) 1985-11-16
DK143483A (da) 1983-10-01
GB2117771B (en) 1985-12-04
JPS58177971A (ja) 1983-10-18
DK162214C (da) 1992-03-16
DD209621A5 (de) 1984-05-16
ES8602655A1 (es) 1985-12-01
ES530186A0 (es) 1985-12-01
DE3381885D1 (de) 1990-10-25
NO164024C (no) 1990-08-22
ES521080A0 (es) 1984-06-01
IE830685L (en) 1983-09-30
FI81088C (fi) 1990-09-10
SE8202023L (sv) 1983-10-01
GB8308657D0 (en) 1983-05-05
EP0097628A3 (en) 1984-07-18

Similar Documents

Publication Publication Date Title
JP3176063B2 (ja) 新規中枢神経作用性置換フェニルアザシクロアルカン類
KR100430022B1 (ko) 신경장애의치료에유용한수용체-작동칼슘채널의신규부위에서활성인화합물
RU2143425C1 (ru) Производные пиперидина, их соли, способы их получения, фармацевтическая композиция на их основе и промежуточные вещества
JP2521191B2 (ja) 新規フェニルエタノ―ルアミノメチルテトラリン化合物
JP3364222B2 (ja) ５−ｈｔ１様アゴニストとしてのカルバゾール誘導体のエナンチオマー
AU723349B2 (en) Coumpounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
EP2032534B1 (en) 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
EP1096926B1 (en) Methods and compounds for treating depression
JPS6135175B2 (en16)
DK2928861T3 (en) AMINOCYCLOBUTAN DERIVATIVES, METHOD OF PREPARING IT AND USING IT AS MEDICINES
JPH06500076A (ja) ピペリジン化合物、その合成およびその使用方法
RU2232753C2 (ru) 4-замещенные пиперидины, фармацевтическая композиция на их основе и способ лечения заболеваний центральной нервной системы
US9463187B2 (en) Methylphenidate derivatives and uses of them
WO2009016214A2 (en) N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
JPS6155906B2 (en16)
US4719219A (en) Phenyl-azacycloalkanes and use thereof in treatment of central nervous system disorders
CA2756876A1 (en) A process for the preparation of frovatriptan and frovatriptan succinate and their synthetic intermediates
RU2465273C2 (ru) ГЕТЕРОЦИКЛИЧЕСКИЕ НИЗКОМОЛЕКУЛЯРНЫЕ sAPP-МИМЕТИКИ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБЫ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
JP4565747B2 (ja) テトラヒドロイソキノリンアルカノール誘導体及びそれを含む薬学的組成物
JPS624250A (ja) ベンズ三置換−２−アミノテトラリン
JP2004514658A (ja) 新規なニューロキニン拮抗剤、その製法及び医薬組成物
EP1790337A2 (en) Methods and compounds for treating depression and other disorders
HK1240927B (zh) 氨基環丁烷衍生物、其製備方法及其用作藥物的用途
HK1130053B (en) 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions